Nav: Home

No association between antiepileptic drug use and dementia

February 13, 2019

Frankfurt, Germany, February 13, 2019 - Epilepsy is a common neurological condition with a prevalence of around 2%. Many antiepileptic drugs are available to prevent epileptic seizures, allowing up to 80 percent of patients to become seizure-free. However, previous research has found a positive association between the use of AEDs and dementia.

The goal of the present study, which will be published in the next issue of Journal of Alzheimer's Disease, was to investigate the hypothetical association between AED use and dementia risk in 101,150 individuals receiving treatment from more than 1,400 physicians in Germany.

"In recent years, it has been suggested that there is a bidirectional relationship between epilepsy and dementia," explains lead investigator Prof. Karel Kostev, Dr MS, from the IQVIA Epidemiology Team based in Frankfurt, Germany. "In view of this, the prescription of antiepileptic drugs might be an effective strategy to prevent cognitive decline and dementia in patients affected by epilepsy. However, some researchers have assumed that AEDs could affect cognition by inhibiting neurotransmission and suppressing neuronal excitability".

This retrospective cohort study used data from the Disease Analyzer database (IQVIA), which compiles information obtained directly and in anonymous format from computer systems used by general practitioners and specialists. This database has already been used in several studies focusing on dementia in recent years.

This study included patients aged ?60 whose first dementia diagnosis was documented between January 2013 and December 2017 (index date). Controls without dementia were matched (1:1) to dementia patients by age, gender, physician (general practitioner or neuropsychiatrist), diagnosis of mild cognitive impairment, and observation time prior to the index date (in years). The index date for the controls was a randomly selected visit between January 2013 and December 2017.

The study included 50,575 patients with dementia and 50,575 controls without dementia. The mean age was 81.0 years (SD=7.4 years), and 61.5% of patients were women. Overall, there was no significant association between any use of AEDs and dementia risk (odds ratio [OR]=0.99). Furthermore, the duration of AED therapy was not associated with a risk of dementia (OR=1.00 per therapy year).

The only group of drugs associated with increased dementia risk were generic levetiracetam brands (OR=1.70, p<0.001) although no association was found for the original levetiracetam brand (OR=0.84, p>0.05).

"The major message of this study is an all-clear for epilepsy patients, who should not fear that their AED use will result in a higher risk of dementia," noted first author Louis Jacob, PhD, of the University of Versailles Saint-Quentin-en-Yvelines (France), "However, it is possible that some of the newest generic brands of levetiracetam may have negative effects on cognitive function in older individuals with epilepsy, and these effects have not yet been investigated." The authors of the study also note that: "These findings must be interpreted with great caution, and more research should be conducted to corroborate these results before any conclusions are drawn".

The study is subject to some limitations, since no data from special epilepsy centers or on epilepsy severity were available. The main strengths of this study are the use of real-world data, the high number of cases and controls available for analysis, and the number of comorbidities and co-prescribed drugs included in the multivariate regression analyses.
-end-
ABOUT THE JOURNAL OF ALZHEIMER'S DISEASE

The Journal of Alzheimer's Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease and clinical trial outcomes. JAD has an Impact Factor of 3.476 according to the 2017 Journal Citation Reports (Clarivate Analytics, 2018). http://www.j-alz.com

ABOUT IOS PRESS

IOS Press is headquartered in Amsterdam with satellite offices in the USA, Germany, India and China and serves the information needs of scientific and medical communities worldwide. IOS Press now publishes over 100 international journals and about 75 book titles each year on subjects ranging from computer sciences and mathematics to medicine and the natural sciences. http://www.iospress.com

IOS Press

Related Dementia Articles:

Latest issue of Alzheimer's & Dementia
Predicting heart disease might also be a warning sign for Alzheimer's; A new way to think about the environment and Alzheimer's research; Most dementia patients don't receive care from physicians who specialize in brain health.
What multilingual nuns can tell us about dementia
A strong ability in languages may help reduce the risk of developing dementia, says a new University of Waterloo study.
Brain changes may help track dementia, even before diagnosis
Even before a dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Could marriage stave off dementia?
Dementia and marital status could be linked, according to a new Michigan State University study that found married people are less likely to experience dementia as they age.
Migraine diagnoses positively associated with all-cause dementia
Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship.
Apathy: The forgotten symptom of dementia
Apathy is the most common neuropsychiatric symptom of dementia, with a bigger impact on function than memory loss -- yet it is under-researched and often forgotten in care.
Dementia looks different in brains of Hispanics
A major new study from the UC Davis Alzheimer's Center has uncovered dramatic differences in the brains of Hispanics with a dementia diagnosis compared with those of non-Hispanic whites and of African Americans.
No association between antiepileptic drug use and dementia
Epilepsy is a common neurological condition with a prevalence of around 2 percent.
Correlation of stroke and dementia with death: A study from the Swedish dementia registry
Patients who died of IS the most common type of dementia was vascular dementia while those died from other causes were most often diagnosed with Alzheimer's dementia (AD).
Military risk factors for dementia
In recent years, there has been growing discussion to better understand the pathophysiological mechanisms of traumatic brain injury and post-traumatic stress disorder and how they may be linked to an increased risk of neurodegenerative diseases including Alzheimer's disease in veterans.
More Dementia News and Dementia Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.